Postnova Analytics GmbH

Rankinestr. 1
86899 Landsberg am Lech
Germany

Phone

postnova.com

About Postnova Analytics

Postnova Analytics are experts in Field-Flow Fractionation (FFF) and Light Scattering technologies - the modern alternative to chromatography. The company introduced the first commercial Asymmetrical Flow FFF (AF4) instrument. This system brought a new level of automation and separation performance to the market.

In 2001 Postnova Analytics acquired FFFractionation – founded by Prof. Giddings the inventor of FFF, a company based in Salt Lake City, Utah that had been a pioneer for the commercialization of FFF technology and Postnova Analytics USA was formed. The new company became the sole provider of all variants of Field-Flow Fractionation. Since 2003 the Postnova headquarter is in Landsberg am Lech which is located in the Greater Munich area in southern Germany.

Postnova Analytics continues to innovate and now offers ‘the FFF-Platform', a broad range of Field-Flow Fractionation and Light Scattering solutions which are ideally suited for gentle, high resolution and matrix-free separations of large molecules and particles which traditional chromatographic techniques cannot perform. FFF coupled to Multi-Angle Light Scattering (MALS) is the modern alternative to liquid chromatography (LC) and size exclusion SEC techniques, especially when it comes to separation, characterization and fractionation of nanoparticles, proteins, antibodies, biomacromolecules, polymers, adhesives, elastomers, rubbers and other large molecules or particles.

Here you will find Postnova Analytics GmbH

See the theme worlds for related content

Topic world Antibodies

Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous

View topic world
Topic world Antibodies

Topic world Antibodies

Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous